•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Datametrex Plans to Focus on AI, Data Centre, and Patent Licensing
Datametrex Announces Name Change and Management Changes
Datametrex Announces Annual and Special Meeting Voting Results
Datametrex Announces Transition to Semi-Annual Financial Reporting
Datametrex Announces Completion of AI-Based Evaluation of 2 Patents and Launch of Licensing Initiative
Datametrex Announces Rebranding of Paymetrex to QuantIP Licensing Corp.
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
Datametrex Receives $1M Order from Fortune 500 Client
Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Paymetrex Secures First U.S. License Payment
Datametrex Expands Business In Data Centres
Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Datametrex Announces Participation in AlphaNorth Capital Event
Paymetrex and AnywhereCommerce Solidify Relationship
DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition